Theravance Biopharma Inc (TBPH)
9.60
-0.13
(-1.34%)
USD |
NASDAQ |
Dec 20, 16:00
9.45
-0.15
(-1.56%)
After-Hours: 20:00
Theravance Biopharma Total Liabilities (Quarterly): 170.45M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 145.42M |
| Madrigal Pharmaceuticals Inc | 296.11M |
| Ionis Pharmaceuticals Inc | 2.419B |
| Jazz Pharmaceuticals PLC | 8.085B |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 356.10M |
| Shareholders Equity (Quarterly) | 185.65M |
| Current Ratio | 4.970 |